Product News
PharmaKure Announces Study Success for Novel Blood Test To Identify Biomarkers in Patients With Alzheimer’s Disease
Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease.
Product News
Cellectricon Expands Neuroscience Contract Research Portfolio With New Neuroplasticity Services
Newly-launched module set to accelerate drug discovery in therapeutic areas such as neuropsychiatry, epilepsy and neurodegeneration.
Product News
New Report Reveals Challenges and Opportunities in Life Science R&D Experiments
Synthace has released a comprehensive analyst report that sheds light on the industry challenges faced by researchers and highlights opportunities for improvement.
Product News
Exploring Neurodegenerative Diseases in Microgravity
AMSBIO, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM).
Product News
Aptamer Group and Neuro-Bio Partner To Develop an Alzheimer’s Disease Diagnostic Test
Aptamer Group plc and Neuro-Bio announce success in the development of Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer’s disease.
Product News
Scribe Announces Collaboration To Accelerate In Vivo CRISPR-Based Genetic Medicines
Scribe Therapeutics Inc. has announced a strategic collaboration with Prevail Therapeutics, granting Prevail exclusive rights to Scribe’s CRISPR X-Editing technologies for the development of in vivo therapies directed to specified targets known to cause serious neurological and neuromuscular diseases.
Advertisement
